BDBM755272 2,2'',2″-(10-(2-((6-((4-((3-((1R,4R,Z)-9-amino-4-((4-hydroxybenzyl)carbamoyl)-1-(isoindolin-2-yl)-2,11,16-trioxo-3,8,10,12,15-pentaazaoctadec-9-en-1-yl)phenyl)amino)-4-oxobutyl)amino)-6-oxohexyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid ::US20250213735, Compound 3B

SMILES CCC(=O)NCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)[C@@H](c1cccc(NC(=O)CCCNC(=O)CCCCCNC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)c1)N1Cc2ccccc2C1)C(=O)NCc1ccc(O)cc1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 755272   

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755272(2,2',2″-(10-(2-((6-((4-((3-((1R,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent